Delphinus Medical Technologies: Funding, Investors & Team (Oct 2026)
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.
Delphinus Medical Technologies has raised $42.4M across 2 funding rounds on record, the most recent an undisclosed round of $12.0M announced in Aug 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Delphinus Medical Technologies Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Delphinus Medical Technologies Funding Rounds
Delphinus Medical Technologies raised $30.4M in an undisclosed round announced in Sep 2022.
11 months later, an undisclosed round of $12.0M was announced in Aug 2023.
Delphinus Medical Technologies Founders and Leadership Team
Contact details for the Delphinus Medical Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Delphinus Medical Technologies Funding Compared to Other Biotechnology Startups
Delphinus Medical Technologies' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Delphinus Medical Technologies in Biotechnology and Novi
Companies Similar to Delphinus Medical Technologies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Delphinus Medical Technologies Funding FAQs
What does Delphinus Medical Technologies do?
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.
How much funding has Delphinus Medical Technologies raised?
Delphinus Medical Technologies has raised $42.4M across 2 rounds on record. The most recent is an undisclosed round of $12.0M announced in Aug 2023.
When did Delphinus Medical Technologies last raise funding?
Delphinus Medical Technologies' most recent funding round on record is an undisclosed round of $12.0M, announced in Aug 2023.
Who founded Delphinus Medical Technologies?
FundedIQ lists Neb Duric (Founder) at Delphinus Medical Technologies.
Where is Delphinus Medical Technologies headquartered?
Delphinus Medical Technologies is based in Novi, Michigan, United States.
How many employees does Delphinus Medical Technologies have?
Delphinus Medical Technologies is in the 11-50 employee band.
How does Delphinus Medical Technologies' funding compare to other Biotechnology startups?
Delphinus Medical Technologies' latest round of $12.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Delphinus Medical Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delphinus Medical Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.